In the United States, senior cats now have their treatment against osteoarthritis

Good news for old felines suffering from osteoarthritis: US health authorities have approved a treatment to reduce their pain.

These are monoclonal antibodies — a type treatment that has received great attention since the Covid-19 pandemic, as it reduces the risk of serious illness.

But this is the first time that synthetic antibodies are authorized for animals.

“Advances in veterinary medicine have been instrumental in extending the life of many animals, including cats,” Steven Solomon said in a statement. , director of the veterinary section of the American Medicines Agency (FDA).

“But longer lives are associated with more chronic diseases, such as osteoarthritis”, he added.

The new drug is administered by subcutaneous injection, once a month. The dosage depends on the weight of the cat.

Osteoarthritis is a disease that affects the joints: with age, the cartilage allowing the sliding of two bones wears out, causing friction that causes pains.

The new treatment, called Solensia, attaches to a protein called NGF which is involved in the regulation of pain. The pain signal is thus prevented from reaching the brain.

During clinical trials, researchers asked cat owners to describe their animal’s behavior: does it jump as much as before from piece of furniture to piece of furniture? Does he wash as much?

This behavior was then compared after taking the treatment.

Mild side effects were observed, such as vomiting or diarrhoea, but did not require discontinuation of treatment.